TABLE 2.
Clinicopathological characteristics of HNRNPC expression on ESCC tissue sections.
| HNRNPC low expression | HNRNPC high expression | P | ||
|---|---|---|---|---|
| 62 (%) | 58 (%) | |||
| Gender | Male | 42 (49.4) | 43 (50.6) | .285 |
| Female | 20 (57.1) | 15 (42.9) | ||
| Age | <55 | 11 (44.0) | 14 (56.0) | .262 |
| ≥55 | 51 (53.7) | 44 (46.3) | ||
| Tumor location | Upper thoracic | 4 (57.1) | 3 (42.9) | .431 |
| Middle thoracic | 47 (54.7) | 39 (45.3) | ||
| Lower Thoracic | 11 (40.7) | 16 (59.3) | ||
| T stage | T1 | 3 (50.0) | 3 (50.0) | <.001* |
| T2 | 22 (91.7) | 2 (8.3) | ||
| T3 | 37 (42.0) | 51 (58.0) | ||
| T4 | 0 (.0) | 2 (100.0) | ||
| N stage | N0 | 23 (39.0) | 36 (61.0) | .041* |
| N1 | 22 (62.9) | 13 (37.1) | ||
| N2 | 14 (70.0) | 6 (30.0) | ||
| N3 | 3 (50.0) | 3 (50.0) | ||
| TNM stage | I | 6 (85.7) | 1 (14.3) | <.001* |
| II | 40 (74.1) | 14 (25.9) | ||
| III | 15 (27.3) | 40 (72.7) | ||
| IV | 1 (25.0) | 3 (75.0) | ||
| Differentiation | High | 7 (53.8) | 6 (46.2) | .566 |
| Moderate | 51 (53.1) | 45 (46.9) | ||
| Low | 4 (36.4) | 7 (63.6) | ||
ESCC, esophageal squamous cell carcinoma; HNRNPC: heterogeneous nuclear ribonucleoprotein C; * Meaningful p-value.